Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon Biologics initiates clinical study for Itolizumab in Lupus Nephritis
Equalise is a phase-Ib open-label, proof-of-concept clinical study currently studying Lupus Nephritis patients in the Part B…
University of Oxford study supports use of Vaxzevria as third-dose booster against Omicron
Neutralising anti-body levels against Omicron following a third-dose boost of Vaxzevria were broadly similar to levels achieved…
UK government to purchase additional 1.75 million courses of Molnupiravir
With this additional procurement agreement, which follows a previously announced agreement for 480,000 courses of treatment, the…
Serum waives AstraZeneca shot indemnity for refugee programme
The news comes days after Reuters reported that tens of millions of migrants may be denied COVID-19 vaccines from the…
Valneva says Chikungunya vaccine phase-III trial has met primary endpoint
In August, after Valneva gave a positive update on the phase-III trial
US FDA authorises first oral antiviral to treat COVID
The antiviral, Paxlovid, is not authorised for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of…
10th Indian Pharma Expo held in Delhi
The event helped the industry to understand the challenges and changes, unique ideas, innovation and execution, cost-effective…
Zydus Cadila receives tentative approval from US FDA for Pimavanserin tablets
The tablets are used to treat the symptoms of a certain mental/mood disorder (psychosis) that might occur with Parkinson's disease
Government approves PLI scheme to boost domestic API production: Dr Mansukh Mandaviya
The total outlay of the scheme is Rs 6,940 crores and financial incentive under the scheme is provided to the selected…
Discerning the next frontier for quality excellence in Indian pharma industry
Express Pharma as part of SAP India's Industry Knowledge Exchange Forum's Expert Speak series, invited pharma quality veteran Dr…